Vol 8: An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device.Report as inadecuate



 Vol 8: An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device.


Vol 8: An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 8: An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device.
This article is from Patient preference and adherence, volume 8.AbstractBackground: Poor adherence to disease-modifying drugs is associated with an increased risk of relapse in patients with multiple sclerosis.
However, adherence is difficult to assess objectively.
RebiSmart® (Merck Serono SA, Geneva, Switzerland), a device for subcutaneous (sc) i

Author: Willis, Helen; Webster, Julie; Larkin, Anne Marie; Parkes, Laura

Source: https://archive.org/